VERAXA Biotech Reports Early Validation of BiTAC-ADC Cancer Therapy Platform

VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC technology platform, a next-generation approach designed to improve... Read More

The post VERAXA Biotech Reports Early Validation of BiTAC-ADC Cancer Therapy Platform appeared first on citybiz.